Ethyl chloroformate → 1-Ethoxycarbonyl-4-((benzothiazol-2-yl)methyl)piperidine
Reaction equation
C([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][C:15]2[S:16][C:17]3[CH:23]=[CH:22][CH:21]=[CH:20][C:18]=3[N:19]=2)[CH2:10][CH2:9]1)C1C=CC=CC=1.Cl[C:25]([O:27][CH2:28][CH3:29])=[O:26]>C1COCC1>[CH2:28]([O:27][C:25]([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][C:15]2[S:16][C:17]3[CH:23]=[CH:22][CH:21]=[CH:20][C:18]=3[N:19]=2)[CH2:10][CH2:9]1)=[O:26])[CH3:29]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 500 mg of 1-benzyl-4-((benzothiazol-2-yl)methyl)piperidine (from EXAMPLE 163, Step D) in 10 mL of THF was added 185 mg of ethyl chloroformate at rt. The reaction was stirred at rt for 5 h. The reaction mixture was partitioned between H2O and EtOAc. The aqueous phase was extracted with EtOAc (3×). The combined organic phases were washed with sat'd NaCl and dried over MgSO4. Concentration afforded 320 mg of the title compound as a oil.
Workup
- customThe reaction mixture was partitioned between H2O and EtOAc
- extractionThe aqueous phase was extracted with EtOAc (3×)
- washThe combined organic phases were washed with sat'd NaCl
- dry with materialdried over MgSO4
- concentrationConcentration
Sources & evidence
- ORD record
- ord-d1675590bc0d469b85cf20ad9de1a05f
- Source dataset
- uspto-grants-2001_07
- Patent number
- US06265434B1
Reaction notes
Loading…